1,090
Views
17
CrossRef citations to date
0
Altmetric
Review

Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management

& ORCID Icon
Pages 3273-3285 | Published online: 25 Nov 2019

References

  • Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–1077. doi:10.1111/j.1528-1167.2009.02397.x19889013
  • Winesett SP, Bessone SK, Kossoff EH. The ketogenic diet in pharmacoresistant childhood epilepsy. Expert Rev Neurother. 2015;15(6):621–628. doi:10.1586/14737175.2015.104498225994046
  • Sharma S, Jain P. The ketogenic diet and other dietary treatments for refractory epilepsy in children. Ann Indian AcadNeurol. 2014;17(3):253–258. doi:10.4103/0972-2327.138471
  • Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics. 2000;105(4):E46. doi:10.1542/peds.105.4.e4610742367
  • Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500–506. doi:10.1016/S1474-4422(08)70092-918456557
  • Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev. 2018;11:CD001903. doi:10.1002/14651858.CD001903.pub430403286
  • Kossoff EH, ZupecKania BA, Auvin S, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of theInternational Ketogenic Diet Study Group. Epilepsia Open. 2018;3:175. doi:10.1002/epi4.1222529881797
  • Veggiotti P, Burlina A, Coppola G, et al. The ketogenic diet for Dravet syndrome and other epileptic encephalopathies: an Italian consensus. Epilepsia. 2011;52(S 2):83–89. doi:10.1111/j.1528-1167.2011.03010.x21463288
  • Sharma S, Tripathi M. Ketogenic diet in epileptic encephalopathies. Epilepsy Res Treat. 2013;2013:652052.23936641
  • Yan N, Xin-Hua W, Lin-Mei Z, Yi-Ming C, Wen-Hui L. Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome. Seizure. 2018;60:144–148. doi:10.1016/j.seizure.2018.06.02329990707
  • Wu Q, Wang H, Fan YY, Zhang JM, Liu XY, Fang XY. Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: a clinical prospective study. Brain Behav. 2018;8(5):e00973. doi:10.1002/brb3.2018.8.issue-529761022
  • Thammongkol S, Vears DF, Bicknell-Royle J, Nation J, Draffin K, Stewart KG. Efficacy of the ketogenic diet: which epilepsies respond? Epilepsia. 2012;53(3):e55–e59. doi:10.1111/epi.2012.53.issue-322310062
  • Caraballo RH, Cersósimo RO, Sakr D, Cresta A, Escobal N, Fejerman N. Ketogenic diet in patients with Dravet syndrome. Epilepsia. 2005;46(9):1539–1544. doi:10.1111/epi.2005.46.issue-916146451
  • Dressler A, Trimmel-Schwahofer P, Reithofer E, et al. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen. Epilepsy Res. 2015;109:81–89. doi:10.1016/j.eplepsyres.2014.10.01425524846
  • Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi KS, Raeisi S. Ketogenic diet: overview,types, and possible anti-seizure mechanisms. Nutr Neurosci. 2019;26:1–10. doi:10.1080/1028415X.2019.1627769
  • Raju KN, Gulati S, Kabra M, et al. Efficacy of 4: 1(classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res. 2011;96(1–2):96–100. doi:10.1016/j.eplepsyres.2011.05.00521621394
  • Huttenlocher PR, Wilbourn AJ, Signore JM. Medium‐chain triglycerides as a therapy for intractable child epilepsy. Neurology. 1971;21:1097–1103. doi:10.1212/WNL.21.11.10975166216
  • Liu YM. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. 2008;49(Suppl 89):33–36. doi:10.1111/j.1528-1167.2008.01830.x
  • Zupec-Kania B, Neal E, Schultz R, Roan ME, Turner Z, Welborn M. An update on diets in clinical practice. J Child Neurol. 2013;28(8):1015–1026. doi:10.1177/088307381348759723674231
  • Sharma S, Jain P. The modified Atkins diet in refractory epilepsy. Epilepsy Res Treat. 2014;2014:404202.24627806
  • Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia. 2013;54(3):481–486. doi:10.1111/epi.2013.54.issue-323294191
  • Sharma S, Jain P, Gulati S, Sankhyan N, Agarwala A. Use of the modified Atkins diet in Lennox Gastaut syndrome. J Child Neurol. 2015;30(5):576–579. doi:10.1177/088307381452716224659735
  • Kim JA, Yoon JR, Lee EJ, et al. of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia. 2016;57(1):51–58. doi:10.1111/epi.1325626662710
  • Sharma S, Goel S, Jain P, Agarwala A, Aneja S. Evaluation of a simplified modified Atkins diet for use by parents with low levels of literacy in children with refractory epilepsy: a randomized controlled trial. Epilepsy Res. 2016;127:152–159. doi:10.1016/j.eplepsyres.2016.09.00227603509
  • Mehta R. Efficacy and tolerability of the modified Atkins diet in young children with refractory epilepsy: Indian experience. Ann Indian Acad Neurol. 2016;19(4):523–527. doi:10.4103/0972-2327.19446327994368
  • Sharma S. Use of the modified Atkins diet in infantile spasms refractory to first-line treatment. Seizure. 2012;21(1):45–48. doi:10.1016/j.seizure.2011.08.00921920781
  • Pfeifer HH, Lyczkowski DA, Thiele EA. Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia. 2008;49:42–45. doi:10.1111/epi.2008.49.issue-s8
  • Kim SH, Kang HC, Lee EJ, et al. Low glycemic index treatment inpatients with drug-resistant epilepsy. Brain Dev. 2017;39:687–692. doi:10.1016/j.braindev.2017.03.02728431772
  • Sondhi V, Agarwala A, Chakrabarty B, et al. Dietary Therapy In EpilepsyTreatment (DIET-Trial): a randomised non-inferiority trial comparing KD, MAD & LGIT for drug resistant epilepsy. Neurology. 2018;90(15 S):S35.006. doi:10.1212/WNL.0000000000005560
  • Grocott OR, Herrington KS, Pfeifer HH, et al. Low glycemic index treatment for seizure control in Angelman syndrome: a case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital. Epilepsy Behav. 2017;68:45–50. doi:10.1016/j.yebeh.2016.12.01828109989
  • Freeman JM, Kossoff EH. Ketosis and the ketogenic diet, 2010: advances in treating epilepsy and other disorders. Adv Pediatr. 2010;57:315–329. doi:10.1016/j.yapd.2010.08.00321056745
  • Likhodii SS, Serbanescu I, Cortez MA, Murphy P, Snead OC III, Burnham WM. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann Neurol. 2003;54:219–226. doi:10.1002/(ISSN)1531-824912891674
  • Masino SA, Rho JM. Mechanisms of ketogenic diet action In: Noebels JL, Avoli M, Rogawski MA,et al editors. Jasper’s Basic Mechanisms of the Epilepsies. 4th ed. Bethesda, MD: National Center for Biotechnology Information (US); 2012;1–35.Available from: https://www.ncbi.nlm.nih.gov/books/NBK98219/.
  • Bromfield E, Dworetzky B, Hurwitz S, et al. A randomized trial of polyunsaturated fatty acids for refractory epilepsy. Epilepsy Behav. 2008;12:187–190. doi:10.1016/j.yebeh.2007.09.01118086463
  • Dahlin M, Hjelte L, Nilsson S, Åmark P. Plasma phospholipid fatty acids are influenced by a ketogenic diet enriched with n-3 fatty acids in children with epilepsy. EpilepsyRes. 2007;73:199–207.
  • Abdallah D. Anticonvulsant potential of the peroxisome proliferator activated receptor gamma agonist pioglitazone in pentylenetetrazole-induced acute seizures and kindling in mice. Brain Res. 2010;1351:246–253. doi:10.1016/j.brainres.2010.06.03420599832
  • Zhang Y, Zhou S, Zhou Y, et al. Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet. Epilepsy Res. 2018;145:163–168. doi:10.1016/j.eplepsyres.2018.06.01530007242
  • Lindefeldt M, Eng A, Darban H, et al. The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy. NPJ Biofilms Microbiomes. 2019;5:5. doi:10.1038/s41522-018-0073-230701077
  • Tagliabue A, Ferraris C, Uggeri F, et al. Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 deficiency syndrome: a 3-month prospective observational study. Clin Nutr ESPEN. 2017;17:33–37. doi:10.1016/j.clnesp.2016.11.00328361745
  • McDaniel SS, Rensing NR, Thio LL, Yamada KA, Wong M. The ketogenic diet inhibits the mammalian target of rapamycin (mTOR) pathway. Epilepsia. 2011;52(3):e7–e11. doi:10.1111/j.1528-1167.2011.02981.x21371020
  • Meira ID, Romão TT, Do Prado HJ, Krüger LT, Pires ME, da Conceição PO. Ketogenic diet and epilepsy: what we know so far. Front Neurosci. 2019;13:1–8. doi:10.3389/fnins.2019.0000130740042
  • Bansal S, Cramp L, Blalock D, et al. The ketogenic diet: initiation at goal calories versus gradual caloric advancement. Pediatr Neurol. 2014;50:26–30. doi:10.1016/j.pediatrneurol.2013.08.00624200038
  • van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol. 2016;20:798–809. doi:10.1016/j.ejpn.2016.07.00927470655
  • McNally MA, Pyzik PL, Rubenstein JE, Hamdy RF, Kossoff EH. Empiric use of oral potassium citrate reduces symptomatic kidney stone incidence with the ketogenic diet. Pediatrics. 2009;124:e300–e304. doi:10.1542/peds.2009-021719596731
  • Lin A, Turner Z, Doerrer SC, Stanfield A, Kossoff EH. Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes. Pediatr Neurol. 2017;68:35–39. doi:10.1016/j.pediatrneurol.2017.01.00728188074
  • Sharma S, Gulati S, Kalra V, Agarwala A, Kabra M. Seizure control and biochemical profile on the ketogenic diet in young children with refractory epilepsy-Indian experience. Seizure. 2009;18(6):446–449. doi:10.1016/j.seizure.2009.04.00119427240
  • Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol. 2007;22:375–378. doi:10.1177/088307380730192617621514
  • Peterson SJ, Tangney CC, Pimentel-Zablah EM, et al. Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. J Am Diet Assoc. 2005;105:718–725. doi:10.1016/j.jada.2005.02.00915883547
  • Neal EG, Chaffe HM, Edwards N, Lawson MS, Schwartz RH, Cross JH. Growth of children on classical and medium chain triglyceride diets. Pediatrics. 2008;122:e334–e340. doi:10.1542/peds.2007-241018676520
  • Bergqvist AGC, Schall JI, Stallings VA, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008;88:1678–1684. doi:10.3945/ajcn.2008.2609919064531
  • Spulber G, Spulber S, Hagenas L, et al. Growth dependence on insulin- like growth factor-1 during the ketogenic diet. Epilepsia. 2009;50:297–303. doi:10.1111/j.1528-1167.2008.01769.x18727678
  • Vining EP, Pyzik P, McGrogan J, et al. Growth of children on the ketogenic diet. DMCN. 2002;44:796–802.
  • Williams S, Basualdo-Hammond C, Curtis R, et al. Growth retardation in children with epilepsy on the ketogenic diet: a retrospective chart review. J Am Diet Assoc. 2002;102:405–407.). doi:10.1016/S0002-8223(02)90093-3
  • Tagliabue A, Bertoli S, Trentani C, Borrelli P, Veggiotti P. Effects of the ketogenic diet on nutritional status, resting energy expenditure, and substrate oxidation in patients with medically refractory epilepsy: a 6-month prospective observational study. Clin Nutr. 2012;31(2):246–249. doi:10.1016/j.clnu.2011.09.01222019282
  • Coppola G, Natale F, Torino A, et al. The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: a case-control study.n. Seizure. 2014;23:260–265. doi:10.1016/j.seizure.2013.12.00224380692
  • Hosain SA, La VegaTalbott M, Solomon GE. Ketogenic diet in pediatric epilepsy patients with gastrostomy feeding. Pediatr Neurol. 2005;32:81. doi:10.1016/j.pediatrneurol.2004.09.00615664765
  • Wijnen BFM, de Kinderen RJA, Lambrechts DAJE, et al. Long-term clinical outcomes and economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy. Epilepsy Res. 2017;132:91–99. doi:10.1016/j.eplepsyres.2017.03.00228364726
  • Poelzer K, Mannion C, Ortiz MM, Bang R, Woods P. A systematic review of the quality of life for families supporting a child consuming the ketogenic diet for seizure reduction. Curr Dev Nutr. 2019;3(5):1–7.). doi:10.1093/cdn/nzy079
  • Best TH, Franz DN, Gilbert DL, et al. Cardiac complications in pediatric patients on the ketogenic diet. Neurology. 2000;54:2328–2330. doi:10.1212/WNL.54.12.232810881264
  • Kang HC, Chung DE, Kim DW, Kim HD. Early and late onset complications of the ketogenic diet for intractable epilepsy. Epilepsia. 2004;45(9):1116–1123. doi:10.1111/epi.2004.45.issue-915329077
  • Patel A, Pyzik PL, Turner Z, Rubenstein JE, Kossoff EH. Long term outcomes of children treated with the ketogenic diet in the past. Epilepsia. 2010;51(7):1277–1282. doi:10.1111/(ISSN)1528-116720132287
  • Takeoka M, Riviello JJ, Pfeifer H, Thiele EA. Concomitant treatment with topiramate and ketogenic diet in pediatric epilepsy. Epilepsia. 2002;43:1072–1075. doi:10.1046/j.1528-1157.2002.00602.x12199733
  • Paul E, Conant KD, Dunne IE, et al. Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Res. 2010;90:151–156. doi:10.1016/j.eplepsyres.2010.04.00520466520
  • Ville D, Chiron C, Laschet J, Dulac O. The ketogenic diet can be used successfully in combination with corticosteroids for epileptic encephalopathies. Epilepsy Behav. 2015;48:61–65. doi:10.1016/j.yebeh.2015.03.00326057351
  • Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warrenburg BP, Willemsen MA. GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol. 2014 261(3):589–599.24413642
  • Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia. 2010;51(8):1403–1407. doi:10.1111/j.1528-1167.2010.02586.x20477843
  • Worden LT, Turner Z, Pyzik PL, Rubenstein JE, Kossoff EH. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res. 2011;95(3):232–236. doi:10.1016/j.eplepsyres.2011.04.00321536412
  • Martinez CC, Pyzik PL, Kossoff EH. Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia. 2007;48:187–190. doi:10.1111/epi.2007.48.issue-117241227
  • Caraballo R, Vaccarezza M, Cersósimo R, et al. Long-term follow up of the ketogenic diet for refractory epilepsy: multicenter Argentineanexperience in 216 pediatric patients. Seizure. 2011;20(8):640–645. doi:10.1016/j.seizure.2011.06.00921763159
  • Le Pichon JB, Thompson L, Gustafson M, Abdelmoity A. Initiating the ketogenic diet in infants with treatment refractory epilepsy while maintaining a breast milk diet. Seizure. 2019;69:41–43. doi:10.1016/j.seizure.2019.03.01730959424
  • Kossoff EH, Al-Macki N, Cervenka MC, et al. What are the minimum requirements for ketogenic diet services in resource-limited regions? Recommendations from the International League Against Epilepsy Task Force for Dietary Therapy. Epilepsia. 2015;56(9):1337–1342. doi:10.1111/epi.1303926033161
  • Caraballo RH, Flesler S, Armeno M, et al. Ketogenic diet in pediatric patients with refractory focal status epilepticus. Epilepsy Res. 2014;108(10):1912–1916. doi:10.1016/j.eplepsyres.2014.09.03325454503
  • Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure. 2016;41:62–65. doi:10.1016/j.seizure.2016.07.00627475280
  • Arya R, Peariso K, Gaínza-Lein M, et al. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus. Epilepsy Res. 2018;144:1–6. doi:10.1016/j.eplepsyres.2018.04.01229727818
  • McDonald TJW, Cervenka MC. Ketogenic diets for adults with highly refractory epilepsy. Epilepsy Curr. 2017;17(6):346–350. doi:10.5698/1535-7597.17.6.34629217974
  • Ye F, Li XJ, Jiang WL, Bin SH, Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol. 2015;11:26–31. doi:10.3988/jcn.2015.11.1.2625628734
  • Cervenka MC, Hocker SE, Koenig M, et al. Phase I/II multicenter ketogenic diet study for adult super-refractory status epilepticus. Neurology. 2017;88(10):938–943. doi:10.1212/WNL.000000000000369028179470
  • Ijff DM, Postulart D, Lambrechts DAJE, et al. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: a randomized controlled trial. Epilepsy Behav. 2016;60:153–157. doi:10.1016/j.yebeh.2016.04.03327206235
  • Abdel-Mannan O, Taylor H, Donner EJ, Sutcliffe AG. A systematic review of sudden unexpected death in epilepsy (SUDEP) in childhood. Epilepsy Behav. 2019;90:99–106. doi:10.1016/j.yebeh.2018.11.00630522060
  • Simeone KA, Matthews SA, Rho JM, Simeone TA. Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsy. Epilepsia. 2016;57(8):178–182. doi:10.1111/epi.2016.57.issue-8
  • Kim TH, Borges K, Petrou S, Reid CA. Triheptanoin reduces seizure susceptibility in a syndrome-specific mouse model of generalized epilepsy. Epilepsy Res. 2013;103(1):101–105. doi:10.1016/j.eplepsyres.2012.09.01623196212
  • Calvert S, Barwick K, Par M, Tan KN, Borges K. A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy. Eur J Paediatr Neurol. 2018;22(6):1074–1080. doi:10.1016/j.ejpn.2018.07.01430126760
  • Dallérac G, Moulard J, Benoist JF, et al. Non-ketogenic combination of nutritional strategies provides robust protection against seizures. Sci Rep. 2017;7(1):5496. doi:10.1038/s41598-017-05542-328710408
  • Kossoff EH, Shields WD. Nonpharmacologic care for patients with Lennox-Gastaut syndrome: ketogenic diets and vagus nerve stimulation. Epilepsia. 2014;55(Suppl 4):29–33. doi:10.1111/epi.12546
  • Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia. 2007;48(1):43–58. doi:10.1111/epi.2007.48.issue-117241207
  • Olson CA, Vuong HE, Yano JM, et al. The gut microbiota mediates the antiseizure effects of the ketogenic diet. Cell. 2018;173(7):1728–1741. doi:10.1016/j.cell.2018.04.02729804833
  • Danial NN, Hartman AL, Stafstrom CE, Thio LL. How does the ketogenic diet work? Four potential mechanisms. J Child Neurol. 2013;28(8):1027–1033. doi:10.1177/088307381348759823670253